Kairos Pharma, Ltd. (KAPA)
$0.23-20.69%Close
SELLCRISIS · day 8
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $5M
- Avg volume
- 2.0M
- Beta
- 1.56
- P/E (TTM)
- -0.84
- Short % float
- 5.77%
- Days to cover
- 1.0
- SI change
- +169.5%
- 1W
- -28.13%
- 1M
- -17.86%
- 3M
- -58.18%
- YTD
- -68.49%
- vs SPY 1W
- -26.93%
- vs SPY 1M
- -21.18%
- vs SPY 3M
- -60.57%
- vs SPY YTD
- -80.25%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- DRMABUYDermata Therapeutics, Inc.RECOVERYQ -27$1.63+14.79%
- VNRXSELLVolitionRx LimitedCRISISQ -10$0.39-7.14%
- ACTUBUYActuate Therapeutics IncRECOVERYQ -27$1.23-3.15%
- HROWSELLHarrow Health, Inc.RECOVERYQ 15$39.80-2.81%
- PASGSELLPassage Bio, Inc.RECOVERYQ -17$4.51+1.58%
- XFORBUYX4 Pharmaceuticals, Inc.RECOVERYQ -12$4.05+0.25%
- AEONSELLAEON Biopharma, Inc.CRISISQ -39$0.20+5.26%
- BFRIBUYBiofrontera Inc.BULLQ -16$1.46-1.35%
- APREBUYAprea Therapeutics, Inc.RECOVERYQ 11$0.81+26.56%
- DCTHSELLDelcath Systems, Inc.BULLQ -25$16.75-2.28%
- BLTEBUYBelite Bio, IncRECOVERYQ 54$158.87-1.36%
- CELCSELLCelcuity Inc.RECOVERYQ 29$90.79-2.93%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 14
- VALUE
- 13
- GROWTH
- 39
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-59.3%
REV YoY-
ROE-98.8%
EPS YoY-
ROA-130.3%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.84
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B1.19
P/FCF-
EV/EBITDA-0.41
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO11.98
ND/EBITDA-
BETA1.56
